The product information provided in this website is intended only for residents of the United States.
About Leadiant Biosciences
Leadiant Biosciences is a research-based pharmaceutical company that dedicates considerable scientific and financial resources to the research, development, and distribution of novel and effective therapies to address patient needs and improve their quality of life. At Leadiant Biosciences, our legacy of serving patients is as strong as the future we envision.
Latest News
Gaithersburg, MD, (February 28, 2017) – Sigma-Tau Pharmaceuticals, Inc., a leader in the development and commercialization of medicines for patients with rare diseases, today announced that the company has changed its name to Leadiant Biosciences, Inc. reaffirming the company’s continued strong commitment to the patient communities it serves.
Patients & Caregivers
At Leadiant Biosciences, we understand that people living with rare diseases have needs that extend far beyond medicine, which is why we provide resources and educational materials to support patients and their families throughout their journeys.
Research and Development
Our world-class scientists partner with physicians, researchers, and leading academic and biotechnology organizations around the world to develop innovative research programs and novel product candidates.
Role of Patients in Research and Drug Development
Patients and caregivers play an increasingly important role in researching and developing new therapies for rare and ultra-rare diseases. This can include funding research through donations, participating in a clinical trial, contributing to a patient registry, working with regulatory decision makers, and sharing experiences to help companies and researchers better understand a disease.
Culture and Career
Leadiant Biosciences is a research-based pharmaceutical company unlike any other. We are united by rare dedication and a unique culture where every employee contributes, and every patient matters.